The global leukemia cancer market is anticipated to grow at a significant CAGR of 5.1% during the forecast period. The high incidence rate of blood cancers and the rise in the incidence of leukemia across the globe will drive the leukemia market. For instance, according to Leukemia & Lymphoma Society, Leukemia, lymphoma, and myeloma are expected to cause the deaths of an estimated 57,750...